LIVALO pitavastatin 2 mg film-coated tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

pitavastatin calcium, Quantity: 2.09 mg (Equivalent: pitavastatin, Qty 2 mg)

Pieejams no:

Advantage Medical Products Consulting Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

pitavastatin calcium

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: colloidal anhydrous silica; triethyl citrate; aluminium magnesium silicate; magnesium stearate; lactose monohydrate; hypromellose; titanium dioxide; hyprolose

Ievadīšanas:

Oral

Vienības iepakojumā:

28, 10, 30, 100

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. Prior to initiating therapy with Livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Produktu pārskats:

Visual Identification: Round biconvex white film-coated tablets embossed on one side with 'KC' and '2' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizācija statuss:

Licence status A

Autorizācija datums:

2013-08-27